Combinatorial targeting of genes regulated by KDM4B may lead to improved methods to suppress peritoneal engraftment of EOC tumor cells, ultimately improving the prognosis of patients with elevated levels of KDM4B. The gene discussed is KDM4B; the disease is neoplasm.